The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study)

PURPOSE: To combine peripheral blood indices and clinical factors in a prognostic score for metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 dichloride ([(223)Ra]RaCl(2)). PATIENTS AND METHODS: Baseline neutrophil-to-lymphocyte ratio (NLR), derived NLR (donor)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauckneht, Matteo, Rebuzzi, Sara Elena, Signori, Alessio, Frantellizzi, Viviana, Murianni, Veronica, Lodi Rizzini, Elisa, Mascia, Manlio, Lavelli, Valentina, Donegani, Maria Isabella, Ponzano, Marta, Gaudiano, Angela, Stazza, Maria Lina, Licari, Maria, Cavallini, Letizia, Laghi, Viola, Cindolo, Luca, Maggi, Martina, Sciarra, Alessandro, Mammucci, Paolo, Sambuceti, Gianmario, Costa, Renato Patrizio, Spanu, Angela, Rubini, Giuseppe, Monari, Fabio, De Vincentis, Giuseppe, Fornarini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803683/
https://www.ncbi.nlm.nih.gov/pubmed/34486070
http://dx.doi.org/10.1007/s00259-021-05550-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803683/
https://www.ncbi.nlm.nih.gov/pubmed/34486070
http://dx.doi.org/10.1007/s00259-021-05550-6

Ejemplares similares